Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California 90095


RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. Celecoxib may be effective in preventing lung cancer in tobacco smokers. PURPOSE: Phase II trial to study the effectiveness of celecoxib in preventing non-small cell lung cancer in tobacco smokers.

Study summary:

OBJECTIVES: - Determine the efficacy and feasibility of celecoxib for chemoprevention of primary non-small cell lung cancer in high-risk tobacco smokers. - Determine the safety and long-term side effects of this drug in this population. OUTLINE: Patients receive oral celecoxib twice daily for 6 months. Patients are followed at 2 weeks and then at 6 months. PROJECTED ACCRUAL: A total of 20 patients will be accrued for this study within 6 months.


Inclusion Criteria: - Age > 45 - Smoked > 20 pack years Exclusion Criteria: - Concurrent use of NSAIDs - Hypersensitivity to celecoxib - Documented allergic-type reaction to sulfonamides - History of allergic reaction, urticaria or asthma to aspirin or other NSAIDs - History of liver dysfunction - Hypertension or cardiac conditions aggravated by fluid retention and edema - Previous history of gastrointestinal ulceration, bleeding, or perforation - Renal dysfunction - End stage respiratory disease - Unstable angina - Other malignancy - Pregnancy - Concurrent use of medication known to alter or be affected by alteration of the hepatic p450 2C9 and 2D6 enzymes - Patents with concurrent medical conditions that may interfere with completion of tests, therapy, or the follow up schedule



Primary Contact:

Principal Investigator
Jenny T. Mao, MD
Jonsson Comprehensive Cancer Center

Backup Contact:


Location Contact:

Los Angeles, California 90095
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.